Latest immunotherapies Stories
Company's First-in-Class Technology Enables Lung-Specific Delivery of RNA in Non-Human Primates LAWRENCEVILLE, N.J., May 21, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN),
Cancer Immunotherapy Month Focuses on Raising Awareness for the Most Promising Form of Cancer Treatment Today New York (PRWEB) May 20, 2015 Cancer immunotherapy,
- Pipeline to include 'off-the-shelf' CAR.TNKs(TM) as well as complementary cellular and immunotherapies SAN DIEGO, May 18, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.
INDIANAPOLIS and MAINZ, Germany, May 11, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel
FACIT partners with Ontario researchers to create new company TORONTO, May 4, 2015 /PRNewswire/ - The Fight Against Cancer Innovation Trust (FACIT) and its partners are pleased
MAINZ, Germany, April 22, 2015 /PRNewswire/ -- Potential for truly personalized treatment of any cancer BioNTech AG [http://www.biontech.de
MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license
NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.
LAKE FOREST, Calif., March 11, 2015 /PRNewswire/ -- Cryoport, Inc.
ALBUQUERQUE, N.M., Feb. 17, 2015 /PRNewswire/ -- Agilvax, Inc.
- A young chicken: also used as a pet name for children.